Clinical TrialsNovo’s Denecimig Shows Tolerability After Direct Switch from Emicizumab i... Novo’s Denecimig Shows Tolerability After Direct Switch from Emicizumab i... Read Post »
Clinical TrialsNovartis Discontinues Lifonebart Development in ALS After ASTRALS Phase 2 F... Novartis Discontinues Lifonebart Development in ALS After ASTRALS Phase 2 F... Read Post »
Health TidingsSironax Brain Delivery Platform Acquired by Novartis Sironax Brain Delivery Platform Acquired by Novartis Read Post »
Clinical TrialsLongeveron Laromestrocel Misses ELPIS II HLHS Endpoint Longeveron Laromestrocel Misses ELPIS II HLHS Endpoint Read Post »
Clinical TrialsRozanolixizumab Shows Limited Benefit in Severe Fibromyalgia Phase 2A Trial Rozanolixizumab Shows Limited Benefit in Severe Fibromyalgia Phase 2A Trial Read Post »
Health TidingsFDA Grants Fast Track Designation to Cesalatamig for PD-(L)1-Refractory NSC... FDA Grants Fast Track Designation to Cesalatamig for PD-(L)1-Refractory NSC... Read Post »
Health Tidings Mergers & AcquisitionsNovo Nordisk and Anthropic Partner to Accelerate AI-Driven Drug Discovery Novo Nordisk and Anthropic Partner to Accelerate AI-Driven Drug Discovery Read Post »
Clinical TrialsBoehringer Ingelheim Stops EASi-KIDNEY Trial of Vicadrostat in Chronic Kidn... Boehringer Ingelheim Stops EASi-KIDNEY Trial of Vicadrostat in Chronic Kidn... Read Post »
Health TidingsGilead Expands Lenacapavir Licenses to Support Potential Once-Yearly HIV Pr... Gilead Expands Lenacapavir Licenses to Support Potential Once-Yearly HIV Pr... Read Post »
Clinical TrialsCan a Decades-Old Heart Drug Break Up Cancer Cell Clusters? Can a Decades-Old Heart Drug Break Up Cancer Cell Clusters? Read Post »
Health TidingsBexicaserin Advances to Phase III DEEp SEA Trial With Completion of Randomi... Bexicaserin Advances to Phase III DEEp SEA Trial With Completion of Randomi... Read Post »
Health TidingsSionna Shifts Focus to Proprietary CFTR Combination Following Phase 2a SION... Sionna Shifts Focus to Proprietary CFTR Combination Following Phase 2a SION... Read Post »
Clinical TrialsSKY-0515 Shows 1.59-Point cUHDRS Benefit in Huntington’s Disease SKY-0515 Shows 1.59-Point cUHDRS Benefit in Huntington’s Disease Read Post »
Health TidingsSling Secures $123M to Advance Oral Linsitinib in Phase 3 Thyroid Eye Disea... Sling Secures $123M to Advance Oral Linsitinib in Phase 3 Thyroid Eye Disea... Read Post »
Clinical TrialsSYNT-101 Shows Placebo-Adjusted Weight Loss in 28-Day Phase 1 Obesity Study SYNT-101 Shows Placebo-Adjusted Weight Loss in 28-Day Phase 1 Obesity Study Read Post »
Health Tidings Mergers & AcquisitionsGSK to Acquire Chimagen’s Trispecific T-Cell Engager for Multiple Myeloma GSK to Acquire Chimagen’s Trispecific T-Cell Engager for Multiple Myeloma Read Post »
Clinical TrialsLilly Advances Obesity and Diabetes Pipeline With New EASD 2026 Data Lilly Advances Obesity and Diabetes Pipeline With New EASD 2026 Data Read Post »
Clinical TrialsNX210c Phase 2 ALS Trial Shows Reduced Functional Decline NX210c Phase 2 ALS Trial Shows Reduced Functional Decline Read Post »
Clinical TrialsRademikibart Improves Lung Function at Day 7 in Phase 2 Asthma Trial; Treat... Rademikibart Improves Lung Function at Day 7 in Phase 2 Asthma Trial; Treat... Read Post »
Health TidingsFDA Accepts Bezuclastinib NDA for Advanced Systemic Mastocytosis FDA Accepts Bezuclastinib NDA for Advanced Systemic Mastocytosis Read Post »
Health TidingsImvax Advances IGV-001 Toward Phase 3 After FDA Alignment in High-Risk Glio... Imvax Advances IGV-001 Toward Phase 3 After FDA Alignment in High-Risk Glio... Read Post »
Health TidingsArrowhead ARO-DIMER-PA Cuts PCSK9 72% and APOC3 88% Arrowhead ARO-DIMER-PA Cuts PCSK9 72% and APOC3 88% Read Post »
Health TidingsBioVie’s Bezisterim Shows Promise in Long COVID Patients with High Sympto... BioVie’s Bezisterim Shows Promise in Long COVID Patients with High Sympto... Read Post »
Health TidingsBH-30643 Shows 45% Response Rate in EGFR C797S NSCLC BH-30643 Shows 45% Response Rate in EGFR C797S NSCLC Read Post »
Clinical TrialsXKH004 Delivers Phase 3 Efficacy in Ankylosing Spondylitis With 45.4% ASAS4... XKH004 Delivers Phase 3 Efficacy in Ankylosing Spondylitis With 45.4% ASAS4... Read Post »
Clinical TrialsIvonescimab Shows Sustained Overall Survival Benefit in EGFR-Mutated NSCLC ... Ivonescimab Shows Sustained Overall Survival Benefit in EGFR-Mutated NSCLC ... Read Post »
Clinical TrialsTRUTAKNA Stabilized Kidney Function and Reduced Risk of Kidney Disease Prog... TRUTAKNA Stabilized Kidney Function and Reduced Risk of Kidney Disease Prog... Read Post »
New Drug ApprovalFDA Approves Curium’s BEXLUTRY as First Radioligand Equivalent to LUTATHE... FDA Approves Curium’s BEXLUTRY as First Radioligand Equivalent to LUTATHE... Read Post »
Health TidingsPerspective Adds Keytruda to Phase 1/2a Trial of FAP-Targeted Alpha Therapy... Perspective Adds Keytruda to Phase 1/2a Trial of FAP-Targeted Alpha Therapy... Read Post »
New Drug ApprovalFDA Approves Ameluz PDT for Superficial Basal Cell Carcinoma FDA Approves Ameluz PDT for Superficial Basal Cell Carcinoma Read Post »
Health TidingsFDA Grants RASONQUE Breakthrough Therapy Designation for First-Line PDAC FDA Grants RASONQUE Breakthrough Therapy Designation for First-Line PDAC Read Post »
Health TidingsBeta Bionics Mint Patch Pump Wins FDA Clearance Beta Bionics Mint Patch Pump Wins FDA Clearance Read Post »
Clinical TrialsContineum’s JNJ-5120/PIPE-307 Misses Phase 2 MDD Endpoint Contineum’s JNJ-5120/PIPE-307 Misses Phase 2 MDD Endpoint Read Post »
Health TidingsFDA Shortens Initial IMDELLTRA Monitoring for Patients With ES-SCLC FDA Shortens Initial IMDELLTRA Monitoring for Patients With ES-SCLC Read Post »
Clinical TrialsRevelyx Bio’s Recombinant Botulinum Toxin YY003 Shows 80.8% Response in P... Revelyx Bio’s Recombinant Botulinum Toxin YY003 Shows 80.8% Response in P... Read Post »
Clinical TrialsTrastuzumab Botidotin Improves Progression-Free Survival Versus T-DM1 in HE... Trastuzumab Botidotin Improves Progression-Free Survival Versus T-DM1 in HE... Read Post »
Health TidingsDefinium’s DT120 ODT Delivers Positive Phase 3 Results in GAD Definium’s DT120 ODT Delivers Positive Phase 3 Results in GAD Read Post »
Clinical TrialsCorbus’s CRB-913 Shows 5% Weight Loss in Phase 1b Obesity Trial Corbus’s CRB-913 Shows 5% Weight Loss in Phase 1b Obesity Trial Read Post »
Health TidingsTakeda Zasocitinib Gets FDA Priority Review for Psoriasis Takeda Zasocitinib Gets FDA Priority Review for Psoriasis Read Post »
Clinical TrialsEnhertu Extends Progression-Free Survival by Six Months in First-Line HER2-... Enhertu Extends Progression-Free Survival by Six Months in First-Line HER2-... Read Post »
Clinical TrialsZipalertinib Plus Chemotherapy Improves Progression-Free Survival in First-... Zipalertinib Plus Chemotherapy Improves Progression-Free Survival in First-... Read Post »
Health TidingsAstraZeneca’s Tagrisso Improves Long-Term Survival in Early-Stage EGFR-Mu... AstraZeneca’s Tagrisso Improves Long-Term Survival in Early-Stage EGFR-Mu... Read Post »
Health TidingsGotistobart Extends Median Survival to 18.5 Months in Previously Treated Sq... Gotistobart Extends Median Survival to 18.5 Months in Previously Treated Sq... Read Post »
New Drug ApprovalFDA Approves Pixclara as First FET-PET Imaging Drug for Glioma FDA Approves Pixclara as First FET-PET Imaging Drug for Glioma Read Post »
Health TidingsJ&J’s Amivantamab Plus Chemotherapy Delivers 34.3-Month Median Overal... J&J’s Amivantamab Plus Chemotherapy Delivers 34.3-Month Median Overal... Read Post »
Clinical TrialsZidesamtinib Shows 94% Response Rate in ROS1-Positive NSCLC Zidesamtinib Shows 94% Response Rate in ROS1-Positive NSCLC Read Post »
Clinical TrialsRis-Rez Extends Survival in Relapsed Small Cell Lung Cancer in Phase III AR... Ris-Rez Extends Survival in Relapsed Small Cell Lung Cancer in Phase III AR... Read Post »
Clinical TrialsRoche’s Tam-Peli Cuts Death Risk by 54% in SCLC Trial Roche’s Tam-Peli Cuts Death Risk by 54% in SCLC Trial Read Post »
New Drug ApprovalPharming Wins FDA Approval to Expand Joenja to Children With APDS Pharming Wins FDA Approval to Expand Joenja to Children With APDS Read Post »
Health TidingsFDA Extends Review of Zanzalintinib Combination in Metastatic Colorectal Ca... FDA Extends Review of Zanzalintinib Combination in Metastatic Colorectal Ca... Read Post »
